FDA approves Clovis' flagship drug for prostate-cancer treatment - BizWest

-

BOULDER — Clovis Oncology Inc. (Nasdaq: CLVS) received approval from federal drug regulators to sell its Rubraca treatment for use in prostate-cancer patients.

The Boulder pharmaceutical company said the drug will be available to prostate cancer patients who haven’t responded to chemotherapy or other existing forms of treatment. The drug was given priority review status in January for an Phase III trial in patients.

“We are pleased that the FDA has granted an accelerated approval for Rubraca in this third indication,” CEO Patrick Mahaffy said in a statement.

Rubraca, which was originally approved for use in 2016 for treating advanced ovarian cancer, is the only product Clovis has greenlit for sale. The company sold $143 million worth of Rubraca in 2019, a $47 million increase from the previous year.


 




Comments

Post a Comment

Popular posts from this blog

Sentinel lymph node biopsy: What cancer patients should know

-
Image
cancer lump on neck :: Article Creator Doctor Watching TV Show Spotted Cancer On Show's Guest That She Didn't Know About Say what you will about social media and daytime TV, but sometimes, they can help work wonders. In fact, the power of Facebook and the popularity of HGTV's Beachfront Bargain Hunt played a big part in helping Nicole McGuiness get ahead of her serious cancer diagnosis - but it was an eagle-eyed doctor who really saved her bacon. The then-32-year-old appeared on the property series alongside her father while in search of a holiday home in North Carolina to celebrate her recent recovery from brain cancer in May 2018. She explained that she had set her sights on 'something near the water', specifically a beachfront property in Morehead City, to start afresh in this new phase of her life. Dr. Erich Voigt was one of the viewers who tuned into the Beachfront Bargain Hunt episode, which Nicole featured in, an...
Read more

Q&A

-
Image
prostate calcification treatment :: Article Creator Treatment Options For Different Stages Of Prostate Cancer Have you or a loved one been diagnosed with prostate cancer? Understanding the various treatment options available for different stages of this disease can empower you to make informed decisions. Navigating the journey through prostate cancer treatment starts with gaining knowledge about how the disease is categorized and what treatments align with each stage. Whether dealing with an early diagnosis or tackling more advanced stages, a spectrum of approaches is designed to manage the disease effectively. This information provides clarity and hope, showcasing the advancements in medical science that are helping individuals lead healthier lives post-diagnosis. Patients and their families need to engage in open discussions with healthcare professionals to understand each treatment option's potential outcomes and side effects. With this...
Read more

What Type of Cancer Causes Low Hemoglobin (Anemia)?

-
Image
diagnostic cancer pancreas :: Article Creator Unlocking Insights Into Pancreatic Cancer And Cachexia In an interview with Targeted Oncology, Sanjay Goel, MD, MS, discussed the mystery of cachexia in pancreatic cancer and why it remains a challenging symptom to target. As 1 of the most lethal cancers, pancreatic cancer remains a disease warranting research and clinical studies. While the lack of targetable mutations and tumor microenvironment make treating pancreatic cancer difficult, 1 of the most challenging symptoms is unrelated to the tumor: cachexia, or more colloquially, wasting syndrome. Cachexia leads to significant muscle mass loss and contributes to poor outcomes in pancreatic cancer treatment. "It's characterized by significant losses in muscle mass, and it's not purely a nutritional deficiency. There are people who believe that overall cachexia is responsible for the deaths of maybe even up to half of all the patien...
Read more